Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish?

With a market cap of $56.2 billion, Becton, Dickinson and Company (BDX) is a global medical technology leader that develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products. Headquartered in Franklin Lakes, New Jersey, BD serves healthcare institutions, life science researchers, and the pharmaceutical industry worldwide.

Shares of the medical device manufacturer have underperformed the broader market over the past 52 weeks. BDX stock has decreased 16.8% over this time frame, while the broader S&P 500 Index ($SPX) has gained 16.1%. Moreover, shares of the company have declined 13.4% on a YTD basis, compared to SPX's 9.6% rise.